Our Insights Chronic Disease Anthony Iannacci 7/28/26 Chronic Disease Anthony Iannacci 7/28/26 Lipfendra Brings PCSK9i Efficacy with Oral Convenience Read More Oncology Anthony Iannacci 2/13/26 Oncology Anthony Iannacci 2/13/26 Keytruda Grabs its 42nd Approval in PD-L1+ PROC Read More Oncology Anthony Iannacci 5/12/22 Oncology Anthony Iannacci 5/12/22 Weighing Efficacy vs. Tolerability: Lenvima + Keytruda in Advanced ccRCC Read More Want to get in touch? Click here
Chronic Disease Anthony Iannacci 7/28/26 Chronic Disease Anthony Iannacci 7/28/26 Lipfendra Brings PCSK9i Efficacy with Oral Convenience Read More
Oncology Anthony Iannacci 2/13/26 Oncology Anthony Iannacci 2/13/26 Keytruda Grabs its 42nd Approval in PD-L1+ PROC Read More
Oncology Anthony Iannacci 5/12/22 Oncology Anthony Iannacci 5/12/22 Weighing Efficacy vs. Tolerability: Lenvima + Keytruda in Advanced ccRCC Read More
